Skip to main content
Article
A phase Ib study of pre-operative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer.
Clinical Cancer Research (2019)
  • David B. Page, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Joanna Pucilowska, Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Katherine G. Sanchez, Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Alison K Conlin, Memorial Sloan Kettering Cancer Center
  • Anupama K Acheson, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Kelly S. Perlewitz, Hematology/Oncology, Providence Cancer Center
  • James H. Imatani, Providence Portland Surgical Specialists, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Shaghayegh Aliabadi-Wahle, Providence Portland Surgical Specialists, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Nicole Moxon, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Staci L. Mellinger, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Amanda Y. Seino, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Martiza Martel, Medical Oncology, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Yaping Wu, Providence Portland Medical Center
  • Zhaoyu Sun, Providence Portland Medical Center
  • William L Redmond, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Valerie K. Conrad, Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Venkatesh Rajamanickam, Providence Health & Services
  • Dottie Waddell, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Deborah Laxague, Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute
  • Monil Shah, Clinical Development, Brooklyn Therapeutics
  • Shu-Ching Chang, Medical Data Research Center, Providence St. Joseph Health
  • Walter J. Urba, Providence Portland Medical Center
Publication Date
January 1, 2019
DOI
10.1158/1078-0432.CCR-19-1119
Citation Information
David B. Page, Joanna Pucilowska, Katherine G. Sanchez, Alison K Conlin, et al.. "A phase Ib study of pre-operative, locoregional IRX-2 cytokine immunotherapy to prime immune responses in patients with early stage breast cancer." Clinical Cancer Research (2019)
Available at: http://works.bepress.com/walter-urba/291/